Reporting their annual results last week, Danone and Nestlé’s leaders were pressed by investors on the impact of the infant formula recalls on earnings and future guidance. The two food and nutrition ...

Danone does not anticipate any tightening of regulations in the wake of the infant-formula recalls as the dairy giant pointed to a negligible impact on sales. As the maker of Aptamil baby formula ...

Thank you for standing by. Welcome to the Danone 2025 Annual Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. Our speakers today will be ...

Protein and medical nutrition powered Danone into growth but soft performance in North America signals a major shift is needed Danone trumped analyst expectations with strong volume-led sales growth ...

Anthropic aired a spicy ad during this year’s Super Bowl, skewering competitor OpenAI’s decision to cram ChatGPT with ads for users who don’t pay for a subscription. “Ads are coming to AI,” the ad’s ...

FY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix up +2.7%, and price up +1.8% Q4 sales up +4.7% LFL, driven again by strong volume/mix, up +2.5%, and price up +2.1% ...

Danone booked a rise in like-for-like revenue for the fourth quarter of 2025, though a series of infant formula recalls have cast a pall over the rosy results. The French food company--which houses ...

PARIS, Feb 20 (Reuters) - French food giant ⁠Danone ⁠delivered fourth-quarter sales growth above expectations ⁠on Friday but said the widespread recall of baby formula could hit sales by up to 70 ...

Ilayaraja Subramanian does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

LONDON, Feb 18 (Reuters) - Nestle and Danone face investor pressure to spell out the financial impact of their biggest infant formula recalls in recent history, and show they have learnt lessons from ...